HCPCS Level II · Outpatient PPS (temporary codes)
C9122Mometasone furoate sinus implant, 10 micrograms (sinuva)
Terminated 03/31/2021
Source: CMS HCPCS quarterly update, October 2026. Page updated September 29, 2026.
About C9122
C9122 is an HCPCS Level II code in the C series (outpatient PPS (temporary codes)), describing mometasone furoate sinus implant, 10 micrograms (sinuva).
It was added to HCPCS effective 07/01/2020, and its current record took effect 04/01/2021.
It was terminated on 03/31/2021 and can't be billed for later dates of service.
Its Medicare coverage code is "D", meaning special Medicare coverage instructions apply.
Details
- Short description
- Mometasone furoate (sinuva)
- Date added
- 07/01/2020
- Action effective
- 04/01/2021
- Termination date
- 03/31/2021
- BETOS
- O1E
Related C91xx codes
Common questions about C9122
Is HCPCS C9122 still valid?
- No. C9122 was terminated on 03/31/2021.
Does Medicare cover C9122?
- Its coverage code is "D": special Medicare coverage instructions apply. Check the local coverage determination for your region.